Mariola is focused on backing founders creating deep tech solutions to transform biology and human health. Before joining BlueYard, she served as an entrepreneur scientist at Flagship Pioneering where she built disruptive new ventures at the interface of artificial intelligence and molecular biology. Prior to joining Flagship, Mariola led industry partnerships at nference in collaboration with the Mayo Clinic and top pharmaceutical companies, leveraging AI/ML and clinical/biomedical datasets to accelerate life science operations from R&D through commercialization. Mariola conducted her PhD research in biophysical modeling and a postdoc in mammalian synthetic biology at the Laufer Center for Physical and Quantitative Biology at Stony Brook University.
